| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $752K | — | +115.3% |
| R&D Expense | $2.8M | — | -9.3% |
| SG&A Expense | $1.2M | — | -10.2% |
| Operating Income | -$4.1M | — | +11.6% |
| Net Income | -$3.2M | — | +28.5% |
| EPS (Basic) | -$0.16 | — | +60.0% |
| EPS (Diluted) | -$0.16 | — | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.9M | -7.2% | +8.9% |
| Current Assets | $17.4M | -8.6% | +2.6% |
| Total Assets | $17.4M | -8.6% | +2.6% |
| Current Liabilities | $3.6M | +60.0% | +45.4% |
| Total Liabilities | $3.6M | +60.0% | +45.4% |
| Stockholders' Equity | $13.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | +74.5% |
| Financing Cash Flow | $505 | — | +0.0% |
| -4.8% |